Hollsteen
← Everpure

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $6.0M · 10-Q 0001564590-16-020289 filed Jun 3, 2016D&A · Q2 FY2016: $8.0M · derived · 10-Q 0001628280-16-019406 filed Sep 6, 2016D&A · Q3 FY2016: $9.0M · derived · 10-Q 0001628280-16-022007 filed Dec 13, 2016D&A · Q4 FY2016: $9.0M · derived · 10-K 0001628280-17-003034 filed Mar 29, 2017D&A · Q1 FY2017: $10.0M · 10-Q 0001564590-16-020289 filed Jun 3, 2016D&A · Q2 FY2017: $12.0M · derived · 10-Q 0001628280-17-009061 filed Sep 5, 2017D&A · Q3 FY2017: $14.0M · derived · 10-Q 0001628280-17-012265 filed Dec 8, 2017D&A · Q4 FY2017: $14.0M · derived · 10-K 0001628280-18-003579 filed Mar 26, 2018D&A · Q1 FY2018: $15.0M · 10-Q 0001628280-17-006263 filed Jun 7, 2017D&A · Q2 FY2018: $15.0M · derived · 10-Q 0001628280-18-011594 filed Sep 4, 2018D&A · Q3 FY2018: $16.0M · derived · 10-Q 0001628280-18-014872 filed Dec 6, 2018D&A · Q4 FY2018: $16.0M · derived · 10-K 0001628280-19-003437 filed Mar 26, 2019D&A · Q1 FY2019: $16.0M · 10-Q 0001628280-18-007756 filed Jun 8, 2018D&A · Q2 FY2019: $17.0M · derived · 10-Q 0001628280-19-011331 filed Aug 30, 2019D&A · Q3 FY2019: $18.0M · derived · 10-Q 0001628280-19-014877 filed Dec 9, 2019D&A · Q4 FY2019: $19.0M · derived · 10-K 0001628280-20-004133 filed Mar 27, 2020D&A · Q1 FY2020: $21.0M · 10-Q 0001628280-19-007753 filed Jun 7, 2019D&A · Q2 FY2020: $23.0M · derived · 10-Q 0001628280-20-013458 filed Sep 11, 2020D&A · Q3 FY2020: $23.0M · derived · 10-Q 0001628280-20-017299 filed Dec 9, 2020D&A · Q4 FY2020: $23.0M · derived · 10-K 0001628280-21-005538 filed Mar 25, 2021D&A · Q1 FY2021: $15.0M · 10-Q 0001628280-20-009289 filed Jun 11, 2020D&A · Q2 FY2021: $14.0M · 10-Q 0001628280-21-018247 filed Sep 8, 2021D&A · Q3 FY2021: $15.0M · 10-Q 0001628280-21-024638 filed Dec 7, 2021D&A · Q4 FY2021: $16.0M · derived · 10-K 0001628280-22-008643 filed Apr 7, 2022D&A · Q1 FY2022: $14.0M · 10-Q 0001628280-22-017288 filed Jun 16, 2022D&A · Q2 FY2022: $15.0M · 10-Q 0001628280-21-018247 filed Sep 8, 2021D&A · Q3 FY2022: $18.0M · 10-Q 0001628280-21-024638 filed Dec 7, 2021D&A · Q4 FY2022: $19.0M · derived · 10-K 0001628280-23-010275 filed Apr 3, 2023D&A · Q1 FY2023: $19.0M · 10-Q 0001628280-22-017288 filed Jun 16, 2022D&A · Q2 FY2023: $20.0M · 10-Q 0001628280-22-024939 filed Sep 15, 2022D&A · Q3 FY2023: $22.0M · 10-Q 0001628280-22-031956 filed Dec 15, 2022D&A · Q4 FY2023: $26.0M · derived · 10-K 0001628280-24-013860 filed Apr 1, 2024D&A · Q1 FY2024: $27.0M · 10-Q 0001628280-23-022333 filed Jun 16, 2023D&A · Q2 FY2024: $27.0M · 10-Q 0001628280-23-032228 filed Sep 14, 2023D&A · Q3 FY2024: $29.0M · 10-Q 0001628280-23-041629 filed Dec 15, 2023D&A · Q4 FY2024: $30.0M · derived · 10-K 0001628280-25-015044 filed Mar 27, 2025D&A · Q1 FY2025: $31.0M · 10-Q 0001628280-24-027955 filed Jun 13, 2024D&A · Q2 FY2025: $33.0M · 10-Q 0001628280-24-040066 filed Sep 11, 2024D&A · Q3 FY2025: $25.0M · 10-Q 0001628280-24-050852 filed Dec 12, 2024D&A · Q4 FY2025: $25.0M · derived · 10-K 0001474432-26-000027 filed Mar 25, 2026D&A · Q1 FY2026: $30.0M · 10-Q 0001628280-25-030567 filed Jun 11, 2025D&A · Q2 FY2026: $33.0M · 10-Q 0001474432-25-000046 filed Sep 10, 2025D&A · Q3 FY2026: $35.0M · 10-Q 0001474432-25-000065 filed Dec 10, 2025D&A · Q4 FY2026: $39.0M · derived · 10-K 0001474432-26-000027 filed Mar 25, 2026D&A · Q1 FY2027: $39.0M · 10-Q 0001474432-26-000061 filed Jun 5, 2026D&A · Q2 FY2027: $41.0M · 10-Q 0001474432-26-000088 filed Sep 4, 202626.0a41.06.5Q1 FY2016Q2 FY2027Q4 FY2023
$MD&A · Q4 FY2022: $19.0M · derived · 10-K 0001628280-23-010275 filed Apr 3, 2023D&A · Q1 FY2023: $19.0M · 10-Q 0001628280-22-017288 filed Jun 16, 2022D&A · Q2 FY2023: $20.0M · 10-Q 0001628280-22-024939 filed Sep 15, 2022D&A · Q3 FY2023: $22.0M · 10-Q 0001628280-22-031956 filed Dec 15, 2022D&A · Q4 FY2023: $26.0M · derived · 10-K 0001628280-24-013860 filed Apr 1, 2024D&A · Q1 FY2024: $27.0M · 10-Q 0001628280-23-022333 filed Jun 16, 2023D&A · Q2 FY2024: $27.0M · 10-Q 0001628280-23-032228 filed Sep 14, 2023D&A · Q3 FY2024: $29.0M · 10-Q 0001628280-23-041629 filed Dec 15, 202326.0a28.718.7aQ4 FY2022Q3 FY2024Q4 FY2023
Q4 FY2023
26.0a$M
derived
All values (46)
PeriodValue ($M)Status
Q2 FY202741.0reported
Q1 FY202738.8reported
Q4 FY202638.6derived
Q3 FY202635.3reported
Q2 FY202632.6reported
Q1 FY202630.3reported
Q4 FY202525.4derived
Q3 FY202524.9reported
Q2 FY202533.1reported
Q1 FY202531.1reported
Q4 FY202430.1derived
Q3 FY202428.7reported
Q2 FY202427.2reported
Q1 FY202426.6reported
Q4 FY202326.0derived
Q3 FY202322.2reported
Q2 FY202319.5reported
Q1 FY202319.3reported
Q4 FY202218.7derived
Q3 FY202217.5reported
Q2 FY202215.2reported
Q1 FY202214.5reported
Q4 FY202116.0derived
Q3 FY202114.9reported
Q2 FY202113.8reported
Q1 FY202115.1reported
Q4 FY202022.9derived
Q3 FY202023.2derived
Q2 FY202022.5derived
Q1 FY202021.1reported
Q4 FY201919.5derived
Q3 FY201917.8derived
Q2 FY201917.2derived
Q1 FY201916.4reported
Q4 FY201816.2derived
Q3 FY201815.5derived
Q2 FY201815.2derived
Q1 FY201814.8reported
Q4 FY201714.2derived
Q3 FY201713.6derived
Q2 FY201711.9derived
Q1 FY201710.4reported
Q4 FY20169.1derived
Q3 FY20168.8derived
Q2 FY20167.8derived
Q1 FY20166.5reported

CSV with all sources · Technical ID: dna

More metrics for Everpure

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$26.0M (derived)
Period
Q4 FY2023, ended Feb 5, 2023 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 87M − 61M = $26.0M (FY value from 10-K 0001628280-24-013860; 9-month value from the Q3-10-Q)
Source
10-K, filed Apr 1, 2024 · 0001628280-24-013860
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$26.0MApr 1, 202410-K 0001628280-24-013860derived · confidence 1. · current